MENU
+Compare
MDEV
ETF ticker: BATS
AS OF
Sep 5, 10:40 AM (EDT)
Price
$20.79
Change
+$0.32 (+1.56%)
Net Assets
2.05M

MDEV stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund’s fees and expenses) of an index called the Indxx Global Medical Devices Index... Show more

Category: #Health
MDEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for MDEV with price predictions
Sep 04, 2025

Momentum Indicator for MDEV turns positive, indicating new upward trend

MDEV saw its Momentum Indicator move above the 0 level on August 29, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned positive. In of the 68 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MDEV just turned positive on August 14, 2025. Looking at past instances where MDEV's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

MDEV moved above its 50-day moving average on August 13, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MDEV crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW), Exact Sciences Corp (NASDAQ:EXAS), Align Technology (NASDAQ:ALGN).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund’s fees and expenses) of an index called the Indxx Global Medical Devices Index. The fund will invest at least 80% of its net assets in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies that are associated with the medical equipment industry, as determined by the index provider.

Market Cap

The average market capitalization across the First Trust Indxx Global Mdcl Dvcs ETF ETF is 50.5B. The market cap for tickers in the group ranges from 218.29M to 231.38B. ABT holds the highest valuation in this group at 231.38B. The lowest valued company is FPH at 218.29M.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Indxx Global Mdcl Dvcs ETF ETF was 1%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was -1%. EXAS experienced the highest price growth at 13%, while AMP experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the First Trust Indxx Global Mdcl Dvcs ETF ETF was -1%. For the same stocks of the ETF, the average monthly volume growth was -1% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 65
Price Growth Rating: 53
SMR Rating: 60
Profit Risk Rating: 74
Seasonality Score: -40 (-100 ... +100)
View a ticker or compare two or three
MDEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Wheaton
Phone
N/A
Web
www.ftportfolios.com